Skip to main content

Closed

PBM: Psyence Biomedical Ltd. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-36.8%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage-655.1×

Current ratio14.62×

Psyence Biomedical Ltd.

PBMNASDAQ Capital Market·USD·Closed

Psyence Biomedical Ltd.

PBMNASDAQ·USD·Closed

$3.17

−5.65%

$3.17

−$0.19 (5.65%)

52W Range

1thpctl

Volume

0.64×avg

Mkt Cap

60290USD

P/E

–TTM

Div Yield

–ann

52W Range

1thpctl

Volume

0.64×avg

Market Cap

60290USD

P/E Ratio

-TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings